A federal judge paused portions of the U.S. Department of Health and Human Services' planned regulatory changes to the ...

Shares of Cigna Group CI rallied 1.13% to $304.35 Friday, on what proved to be an all-around favorable trading session for ...

The U.S. District Court of Maryland on Friday issued a preliminary injunction halting the Trump administration from making ...

Cigna Group has been making subtle yet noticeable gains, with its share price now exceeding $300 and showcasing a ...

In filings with the state, insurance companies blamed the price increases on growing health care costs and increasing use of ...

Children living with sickle cell disease often face many challenges that affect their day to day lives. For many, that also means avoiding the swimming pool. And now, a new ...

A federal judge is letting a medical practice in New Jersey move forward with a suit over a fax sent by a Cigna subsidiary.

Tiffany Dennis from Golden 1 Credit Union shares insight on the benefit selection process and advice on how to launch a ...

Courts and regulators are signaling that a company’s duty to explain automated decisions is rapidly becoming a standard ...

An upcoming policy from Cigna Healthcare will focus on codes for office visits, but the move is concerning one spine surgeon. Effective Oct. 1, Cigna’s new Evaluation and Management Coding Accuracy ...

CVS Health (CVS) won't include Gilead's (GILD) new HIV drug Yeztugo in its commercial healthcare plans, due to clinical, regulatory and financial factors. Read more here.

The Cigna Group (NYSE:CI) is one of the deep value stocks to buy according to analysts. Cigna’s shares are up about 4% ...